Overall rank by patents
#23,022
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 6 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
The verdict
According to USPTO PatentsView, Moxxly ranks #23,022 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R23022 · US Corporation #23,022 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Modulex Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Moxxly · this assignee
37 score
3D Lighting Innovati… · lowest
7 score
What this shows Moxxly's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Moxxly, Llc is a focused PatentsView assignee: 6 CPC subclasses with 83.3% of grants classified under A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). Peak complete grant year is 2022 (5 grants) versus a trough of 2 in 2019. By volume, Moxxly sits between Modulex Inc. and Myeloid Therapeutics, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MODULEX INC.
12 patents
MODUS TEST, LLC
12 patents
MOFFETT INTERNATIONAL CO., LIMITED
12 patents
MORPHIX, INC.
12 patents
MTFY LIMITED
12 patents
MULTIVAC Marking & Inspection GmbH & Co. KG
12 patents
MYCOMAGIC BIOTECHNOLOGY CO., LTD.
12 patents
MYELOID THERAPEUTICS, INC.
12 patents
MOXXLY, LLC
12 patents
What this shows Moxxly holds 12 patents at rank #22,967, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #22,967 in granted patent volume.
Other assignees with the most granted patents in Moxxly's primary technology class.
Moxxly's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 44% higher than 56% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 2 | 16.7% |
| 2020 | 2 | 16.7% |
| 2022 | 5 | 41.7% |
| 2023 | 2 | 16.7% |
| 2025partial year | 1 | 8.3% |
Top 6 of 6 technology areas
Overall rank by patents
#23,022
of 50,000 tracked assignees
37.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.